Skip to content

Life Sciences

From Viet Nam to Europe: three registration pathways

  • Life Sciences
  • 1 min read

Vietnamese manufacturers looking at Europe usually ask about the dossier first. The facility question has to be answered earlier.

There are three realistic pathways, and they differ mostly in time and in where the risk sits.

  1. Acquire an existing marketing authorisation and transfer the manufacturing site. Often the fastest route to a product on the market, if a suitable MA is available. The work is a site transfer variation, comparability data and an EU GMP inspection of the Vietnamese site.
  2. New registration via technology transfer. A product developed elsewhere is transferred in, and a new dossier in CTD/eCTD format is built around the Vietnamese site's data.
  3. In-house development. Full control of the product and the data, and the longest timeline, with a complete dossier at the end.

Whatever the route, some things are common to all three: an EU GMP-compliant quality system and site, a marketing authorisation holder established in the EU, a Qualified Person to certify batches for release, and a pharmacovigilance system.

On the facility side, a plant designed and operated to WHO-GMP may need real changes to pass an EU inspection, particularly for sterile products under the 2022 Annex 1.

Our EU-GMP roadmap work covers QMS, dossier, technology transfer, MAH, QP and pharmacovigilance arrangements, alongside the facility engineering itself.

Industries

Related

More on this subject

What ends the life of a HEPA filter

EU GMP Annex 1 (2022) asks for an integrity test of final filters at requalification and puts no age on the filter. A terminal HEPA is replaced when a leak cannot be repaired within site limits, when pressure drop reaches the manufacturer's final value, or after damage or wetting. On glass-fibre media, dust loading alone does not lower efficiency.

InsightRead

Set a device assembly room's class from the product's risk

ISO 13485 §6.4.2 asks for documented contamination control without naming a cleanroom class. Setting the class from sterilisation method, patient contact and bioburden sensitivity often lands device assembly at ISO 8, with ISO 7 only where needed, less air than Grade C, a smaller AHU and a reason an auditor can read.

InsightRead